Berlin Germany Brandenburg Gate
Pharma

Lilly, Boehringer slash investment plans in Germany

In response to a healthcare reform initiative in Germany, Lilly and Boehringer have slashed their planned investments there, each by at least $1B.
Kevin Dunleavy Jun 3, 2026 3:10pm
Food and Drug Administration

Regulatory tracker: AbbVie, Amgen score separate EU approvals

Jun 3, 2026 2:50pm
ASCO exhibit hall entrence

Beaches, birds and more—a tour of ASCO’s exhibit hall floor

Jun 3, 2026 1:28pm
zebra

Zevra CEO drafts big ambitions for Miplyffa's US adoption curve

Jun 3, 2026 11:17am
Kite

Gilead expanding access to Yescarta, Tecartus with Cencora deal

Jun 3, 2026 11:11am
ASCO

At ASCO, China biotech industry cements its coming of age

Jun 3, 2026 8:50am
More News

FDA posts untitled letter for emails with eye-catching graphics

Jun 3, 2026 4:22am

Marilyn Monroe profiled in endometriosis awareness push

Jun 2, 2026 3:58pm
Fierce Biotech

Roche oral SERD's 1st-line miss spurs new adjuvant trial

Jun 2, 2026 12:45pm
Fierce Healthcare

Eli Lilly to hospitals: Send 340B claims data or lose discounts

Jun 2, 2026 12:00pm